The Subdermal Contraceptive Implants Market was valued at USD 1.1 billion in 2024 and is projected to reach USD 1.14 billion in 2025 and USD 1.6 billion by 2034, growing at a CAGR of 3.90% during the forecast period 2025–2034, according to Polaris Market Research. The market is segmented by product, implant type (single rod and two-rod), end-use (hospitals, clinics, and others), and region. Growth reflects rising demand for reliable, long-term contraceptive methods and investment in the healthcare sector. North America was the largest regional market in 2024.

Hospital End-Use Segment Expected to Post the Fastest CAGR

The hospital end-use segment is expected to witness the fastest CAGR during the forecast period. Hospitals are high-traffic environments where many patients seek healthcare services, giving them an advantage in attracting patients who want contraceptive services, including implants. A diverse patient population contributes to higher adoption of subdermal implants in this setting.

Hospitals also offer advanced healthcare infrastructure and equipment, enabling providers to present a wide range of contraceptive options and improving patient confidence. Integrated care, including gynecological examinations, counseling, and follow-up care under one roof, further contributes to the preference for the hospital end-use segment.

Quick Return to Fertility and Modern Contraceptive Methods Shape Demand

Implants can be easily removed for a quick return to fertility, a feature that, alongside high effectiveness and affordability, has raised demand. Awareness of modern contraceptive methods is also a growth lever in emerging markets. According to the World Health Organization, approximately 214 million women in developing economies like India who wish to prevent pregnancy do not currently use modern contraceptive methods, including subdermal implants. Implants work by modifying the endometrium, suppressing ovulation, and increasing the viscosity of cervical mucus.

In Indonesia, around 64.0% of married women use contraception, with approximately 57% relying on modern methods and about 7.0% opting for traditional methods.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/subdermal-contraceptive-implants-market

Government Programs Strengthen the Contraceptive Supply Chain

Countries such as Tanzania and the United States are implementing measures to increase availability and strengthen the contraceptive supply chain for devices and products. Insurance plans often cover FDA-approved birth control, and governments worldwide are taking initiatives to improve access to subdermal implants. These factors contribute to growing demand and add to the scope of the Subdermal Contraceptive Implants Market. Global demand is also supported by a growing population and rising healthcare expenditure, with increasing demand from countries such as China, Japan, and India.

Regional Analysis: North America Leads, Asia Pacific Accelerates

North America accounted for the largest market share in 2024, driven by established technological advancements, healthcare infrastructure, and growing research and development activities. Rising health concerns, a growing number of unwanted pregnancies, and awareness of efficient contraceptives, including affordable implants, have fueled demand. The region has also witnessed increasing abortions, contributing to market growth. High disposable income and supportive healthcare programs add further support. Data from the Guttmacher Institute indicated a significant number of pregnancies, unwanted pregnancies, and abortions in North America, emphasizing the need for effective contraceptive methods.

Asia Pacific is expected to experience the fastest growth during the forecast period, driven by heightened awareness and initiatives by governments and private organizations to improve women's access to contraceptive methods.

Innovation Pipeline and Key Players

In April 2022, ProMed Pharma commenced a preclinical assessment of an innovative, fully resorbable contraceptive implant, made possible by funding from the Bill & Melinda Gates Foundation. Such development activity signals continued product innovation within the Subdermal Contraceptive Implants Market. Global players are also expanding their presence in developing countries to tap the potential market.

Key players include Allergan plc, Bayer AG, Karex Industries, Mayer Laboratories, Merck & Co., Inc., Nexplanon, Reckitt Benckiser Group plc, Shanghai Dahua Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd., and The Female Health Company. Polaris rates rivalry among existing firms as high and the threat of new entrants as low. Established players pursue research and development, mergers and acquisitions, and technological innovation to maintain a competitive edge.

More Trending Latest Reports By Polaris Market Research:

customer-success-management-market

non-invasive-cancer-diagnostics-market

military-simulation-and-virtual-training-market

laundry-chemicals-market

viral-vector-and-plasmid-dna-manufacturing-market

distributed-energy-resource-management-system-market

fetal-bovine-serum-market

rare-earth-metals-market

future-of-robotics-market

cloud-based-contact-center-market